Guardant Health, Inc. (GH) has a consensus analyst rating of Buy, based on 30 analysts covering the stock. Of those, 28 recommend buying, 1 recommend holding, and 1 recommend selling.
The analyst consensus price target for GH is $134.21, representing a +55.3% upside from the current price of $86.4. Price targets range from a low of $110.00 to a high of $175.00.
